GGrantIndex
Sort

15,440 grants matching organoids

Neutrophil responses Drive Severe Asthma

$680,620
Max A Seibold · Northwestern University At Chicago · U19 · FY2025 · AI

Targeting FGFR Alterations in Gastroesophageal Cancer

$680,532
Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2025 · CA

Functional Biointegration of Bioengineered Salivary Tissues in Irradiated Animal Models

$680,277
Mary C Farach-Carson · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · DE

Leveraging 3D bioprinted organoid constructs to pattern and model human brain development

$680,146
Steven A Sloan · Emory University · R01 · FY2021 · MH

High-throughput identification of causal variants underlying neuropsychiatric disease-related GWAS hits

$680,135
Joseph C Corbo · Washington University · R01 · FY2024 · MH

Immunometabolic regulation of CD8+ T cell mediated intestinal epithelial cell death in people with HIV (PWH)

$679,703
Douglas Kwon · Massachusetts General Hospital · R01 · FY2024 · DK

Intervention Strategies for Non-Folate Responsive Neural Tube Defects

$679,691
Richard H. Finnell · Baylor College Of Medicine · R01 · FY2021 · HD

Target Host Epigenetic Regulation of HIV Proviruses to Reinforce Viral Deep Latency in Microglia

$679,675
Jian Zhu · Ohio State University · R01 · FY2025 · MH

Improving the Safety of Genome Editing With Human Kidney Organoids

$679,632
Benjamin Solomon Freedman · University Of Washington · U01 · FY2020 · DK

Single-cell mitochondrial mutation lineage tracing of non-dysplastic and dysplastic Barrett's esophagus

$679,255
Sydney Shaffer · University Of Pennsylvania · R01 · FY2025 · DK

Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells

$679,188
Mark Jesus Magbanua · University Of California, San Francisco · R01 · FY2024 · CA

Platform to accurately recapitulate and perturb cortical development and morphogenesis in vitro

$679,072
Sharad Ramanathan · Harvard University · R01 · FY2025 · MH

Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade

$678,954
Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2019 · CA

Improving radiolabeled imaging and targeting of HER2 positive EG cancers using lovastatin

$678,920
Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Epigenetic re-establishment of tumor suppression in glioblastoma

$678,879
Alea Mills · Cold Spring Harbor Laboratory · R01 · FY2024 · CA

Epigenetic re-establishment of tumor suppression in glioblastoma

$678,879
Alea Mills · Cold Spring Harbor Laboratory · R01 · FY2025 · CA

Role Of Innate Immunity to NeuroHIV in the cART Era

$678,674
Joao Filipe Inacio Mamede · Rush University Medical Center · R01 · FY2025 · MH

Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression

$678,579
Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · DK

Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer

$678,271
Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

miR-615, AKT/eNOS signaling, and angiogenesis

$678,268
Mark W Feinberg · Brigham And Women'S Hospital · R01 · FY2021 · HL

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$678,087
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Antidepressant regulation of PDAC

$677,974
Valerie Marie Weaver · University Of California, San Francisco · U01 · FY2025 · CA

Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD

$677,710
Elliot Chaikof · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK

Identifying Neutrophil Specific Mechanisms for Resistance to Biologics in Ulcerative Colitis

$677,602
Ronen Sumagin · Northwestern University At Chicago · R01 · FY2025 · DK

Using artificial intelligence to discover spatial, genomic, and pathologic biomarkers to guide and augment immune checkpoint inhibitor therapy for gastric cancer

$677,533
Sam C. Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA